Aprogen Medicines Inc. (KRX:007460)

South Korea flag South Korea · Delayed Price · Currency is KRW
622.00
-4.00 (-0.64%)
At close: Nov 25, 2025
-47.02%
Market Cap191.92B
Revenue (ttm)126.09B
Net Income (ttm)-50.93B
Shares Out308.55M
EPS (ttm)-175.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,564,585
Average Volume6,774,154
Open626.00
Previous Close626.00
Day's Range610.00 - 641.00
52-Week Range556.00 - 1,229.00
Beta0.09
RSI48.05
Earnings DateNov 13, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates
Founded 1971
Employees 256
Stock Exchange Korea Stock Exchange
Ticker Symbol 007460
Full Company Profile

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.

Financial Statements

News

There is no news available yet.